| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Warren Eric60 | Chief Commercial Officer | Sell | 123 | $2.26 | $277.98 | - | -57.0% | +37.6% | |
| Dec 17, 2024 | Halladay Benjamin | Chief Financial Officer | Sell | 3,245 | $2.42 | $7,865.88 | -1.3% | -37.4% | +48.4% | |
| Dec 17, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 2,234 | $2.43 | $5,426.39 | -1.4% | -37.4% | +48.4% | |
| Dec 17, 2024 | Koenig Sheldon L.60 | President And CEO | Sell | 12,447 | $2.47 | $30,694.30 | -1.7% | -37.4% | +48.4% | |
| Nov 19, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 197 | $2.17 | $426.51 | -0.1% | -22.4% | +15.8% | |
| Oct 17, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 107 | $2.12 | $226.73 | - | +4.7% | +30.3% | |
| Sep 17, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 2,608 | $1.78 | $4,650.06 | -1.6% | +30.9% | +52.8% | |
| Sep 17, 2024 | Koenig Sheldon L.60 | President And CEO | Sell | 14,550 | $1.80 | $26,131.80 | -1.9% | +30.9% | +52.8% | |
| Aug 19, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 211 | $1.95 | $410.61 | -0.1% | +13.2% | +7.4% | |
| Jul 17, 2024 | Warren Eric60 | Chief Commercial Officer | Sell | 108 | $2.59 | $279.40 | - | -18.7% | -52.7% |